Targeted DNA vaccines for enhanced induction of Idiotype (Id)-specific B and T cells

Background: Idiotopes (Id) are antigenic determinants localized in variable (V) regions of Ig. Id-specific T and B cells (antibodies) play a role in immunotherapy of Id+ tumors. However, vaccine strategies that enhance Id-specific responses are needed. Methods: Id+ single chain Fragment variable (sc...

Full description

Bibliographic Details
Main Authors: Agnete Brunsvik Fredriksen, Inger eSandlie, Bjarne eBogen
Format: Article
Language:English
Published: Frontiers Media S.A. 2012-10-01
Series:Frontiers in Oncology
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fonc.2012.00154/full
_version_ 1818608319308234752
author Agnete Brunsvik Fredriksen
Inger eSandlie
Bjarne eBogen
author_facet Agnete Brunsvik Fredriksen
Inger eSandlie
Bjarne eBogen
author_sort Agnete Brunsvik Fredriksen
collection DOAJ
description Background: Idiotopes (Id) are antigenic determinants localized in variable (V) regions of Ig. Id-specific T and B cells (antibodies) play a role in immunotherapy of Id+ tumors. However, vaccine strategies that enhance Id-specific responses are needed. Methods: Id+ single chain Fragment variable (scFv) from multiple myelomas and B cell lymphomas were prepared in a fusion format that bivalently target surface molecules on antigen presenting cells (APC). APC-specific targeting units were either scFv from APC-specific mAb (anti-MHCII, anti-CD40) or chemokines (MIP-1α, RANTES). Homodimeric Id-vaccines were injected intramuscularly or intradermally as plasmids in mice, combined with electroporation. Results: (i) Transfected cells secreted plasmid-encoded Id+ fusion proteins to extracellular fluid followed by binding of vaccine molecules to APC. (ii) Targeted vaccine molecules increased Id-specific B and T cell responses. (iii) Bivalency and xenogeneic sequences both contributed to enhanced responses. (iv) Targeted Id DNA vaccines induced tumor resistance against challenges with Id+ tumors. (v) Human MIP-1α targeting units enhanced Id-specific responses in mice, due to a cross reaction with murine chemokine receptors. Thus, targeted vaccines designed for humans can be quality tested in mice. (vi) Human Id+ scFv from 4 multiple myeloma patients were inserted into the vaccine format and were successfully tested in mice. (vii) Human MIP-1α vaccine proteins enhanced human T cell responses in vitro (viii) A hypothetical model for how the APC-targeted vaccine molecules enhance Id-specific T and B cells is presented. Conclusions: Targeted DNA Id-vaccines show promising results in preclinical studies, paving the way for testing in patients.
first_indexed 2024-12-16T14:40:45Z
format Article
id doaj.art-b253c16077df4069a5ee971c106bb3fb
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-16T14:40:45Z
publishDate 2012-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-b253c16077df4069a5ee971c106bb3fb2022-12-21T22:27:56ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2012-10-01210.3389/fonc.2012.0015436351Targeted DNA vaccines for enhanced induction of Idiotype (Id)-specific B and T cellsAgnete Brunsvik Fredriksen0Inger eSandlie1Bjarne eBogen2University of Oslo and Oslo University HospitalUniversity of Oslo and Oslo University HospitalUniversity of Oslo and Oslo University HospitalBackground: Idiotopes (Id) are antigenic determinants localized in variable (V) regions of Ig. Id-specific T and B cells (antibodies) play a role in immunotherapy of Id+ tumors. However, vaccine strategies that enhance Id-specific responses are needed. Methods: Id+ single chain Fragment variable (scFv) from multiple myelomas and B cell lymphomas were prepared in a fusion format that bivalently target surface molecules on antigen presenting cells (APC). APC-specific targeting units were either scFv from APC-specific mAb (anti-MHCII, anti-CD40) or chemokines (MIP-1α, RANTES). Homodimeric Id-vaccines were injected intramuscularly or intradermally as plasmids in mice, combined with electroporation. Results: (i) Transfected cells secreted plasmid-encoded Id+ fusion proteins to extracellular fluid followed by binding of vaccine molecules to APC. (ii) Targeted vaccine molecules increased Id-specific B and T cell responses. (iii) Bivalency and xenogeneic sequences both contributed to enhanced responses. (iv) Targeted Id DNA vaccines induced tumor resistance against challenges with Id+ tumors. (v) Human MIP-1α targeting units enhanced Id-specific responses in mice, due to a cross reaction with murine chemokine receptors. Thus, targeted vaccines designed for humans can be quality tested in mice. (vi) Human Id+ scFv from 4 multiple myeloma patients were inserted into the vaccine format and were successfully tested in mice. (vii) Human MIP-1α vaccine proteins enhanced human T cell responses in vitro (viii) A hypothetical model for how the APC-targeted vaccine molecules enhance Id-specific T and B cells is presented. Conclusions: Targeted DNA Id-vaccines show promising results in preclinical studies, paving the way for testing in patients.http://journal.frontiersin.org/Journal/10.3389/fonc.2012.00154/fullLymphomaMultiple MyelomaVaccineantigen presenting cellsIdiotype
spellingShingle Agnete Brunsvik Fredriksen
Inger eSandlie
Bjarne eBogen
Targeted DNA vaccines for enhanced induction of Idiotype (Id)-specific B and T cells
Frontiers in Oncology
Lymphoma
Multiple Myeloma
Vaccine
antigen presenting cells
Idiotype
title Targeted DNA vaccines for enhanced induction of Idiotype (Id)-specific B and T cells
title_full Targeted DNA vaccines for enhanced induction of Idiotype (Id)-specific B and T cells
title_fullStr Targeted DNA vaccines for enhanced induction of Idiotype (Id)-specific B and T cells
title_full_unstemmed Targeted DNA vaccines for enhanced induction of Idiotype (Id)-specific B and T cells
title_short Targeted DNA vaccines for enhanced induction of Idiotype (Id)-specific B and T cells
title_sort targeted dna vaccines for enhanced induction of idiotype id specific b and t cells
topic Lymphoma
Multiple Myeloma
Vaccine
antigen presenting cells
Idiotype
url http://journal.frontiersin.org/Journal/10.3389/fonc.2012.00154/full
work_keys_str_mv AT agnetebrunsvikfredriksen targeteddnavaccinesforenhancedinductionofidiotypeidspecificbandtcells
AT ingeresandlie targeteddnavaccinesforenhancedinductionofidiotypeidspecificbandtcells
AT bjarneebogen targeteddnavaccinesforenhancedinductionofidiotypeidspecificbandtcells